<p> Ms. Sriram has over 25 years of experience in biopharmaceutical R&D, with hands-on knowledge of driving biologics from early research to human clinical trials. She joined GangaGen in 2001 and has held various leadership roles, helping to establish the R&D infrastructure at GangaGen and has built and led multidisciplinary teams towards development of therapeutic phages and phage-derived antibacterial proteins for human therapy.</p>

<p> Prior to joining GangaGen, Ms. Sriram gained extensive experience in chemistry, manufacturing and controls and regulatory requirements for Bio-therapeutics at Dr. Reddy’s Laboratories, where she was Head of Process Validation and Quality Control. Earlier in her career, she developed DNA-based diagnostics for cerebral malaria and researched anti-malarial compounds for in vitro and in vivo efficacy at Astra Research Center India (Astra Zeneca).</p>

<p> After completing her Master’s Degree in Clinical Biochemistry, she pursued a Master of Philosophy in Biotechnology from the University of Poona. She is the author of several scientific publications in peer-reviewed journals. Ms. Sriram is an inventor on several patents related to GangaGen’s phage and phage-derived technology.</p>